An interventional study of Carboxymethylcellulose and Glycerin based artificial tear and Carboxymethylcellulose in Dry Eye Syndrome, sponsored by Allergan. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-12-14.
Sponsored by Allergan (part of AbbVie) · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Dry Eye Syndromes by AbbVie — 1 open to participants now, 1 under way, none of them phase 3. Dry Eye Syndromes · AbbVie.
Among the 48 studies in Dry Eye Syndromes by AbbVie, this one is the 13th largest by enrollment of the 40 interventional ones that give a count, is one of 4 that started in 2007, is one of 11 with no phase, and was the 4th registered.
1,369 studies on the registry are indexed under Dry Eye Syndromes; 208 are open to participants now.
Browse Dry Eye Syndromes studies →1 of the 48 studies in Dry Eye Syndromes by AbbVie is open now, in 3 countries. Recruiting first, the newest first:
AbbVie · Sites in United States, France, Netherlands
Ages 18–75
By country, each count listing its studies:
Of the 116 Dry Eye Syndromes studies recruiting now, 73 (63%) set no upper age limit and 24 (21%) stop at 75 or younger; 7 take children under 18; 29 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5 · Phase 3 13 · Phase 4 9
First in 2001; this study’s year is marked. 4 started in 2007.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 228 is above the median of 60 across 1,129 interventional studies indexed under Dry Eye Syndromes.
Median enrollment 80 across the 40 interventional studies, 128 across the 8 observational. Of the 47 that completed or were terminated, 40 (85%) have results posted.
This tab as a report to print or save as PDF → With an account.
This study is registered under Allergan, one of the names counted as AbbVie. Under that name alone:
Allergan is the lead sponsor of 505 studies on the registry; none are open to participants now.
Of its 93 completed or terminated interventional studies of FDA-regulated products, 91 (98%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 48 studies in Dry Eye Syndromes by AbbVie, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Carboxymethylcellulose and Glycerin based artificial tear
Drug: Carboxymethylcellulose and Glycerin based artificial tear
Carboxymethylcellulose based artificial tear
Drug: Carboxymethylcellulose
As directed by Investigator at the end of each study visit: 1 to 2 drops in each eye, 1 to 2 times a day up to every hour while awake
As directed by Investigator at the end of each study visit: 1 to 2 drops in each eye, 1 to 2 times a day up to every hour while awake
Also known as: Refresh Plus®
Post LASIK Dry Eye Symptoms as Measured by Ocular Surface Disease Index (OSDI©) Score at Day 90
Measured on 12 domains (categories); a 5-point scale for each domain (0 = best, no dry eye symptoms, 4 = worst, constant dry eye symptoms). Sum of the domain scores is normalized (standardized) to a severity scale of 0-100 (0 = no symptoms (best score), 100 = maximum severity (worst score)).
Time frame: Day 90
Patient Acceptability- Percentage of Patients Who Rated Artificial Tears (AT) as Acceptable at Day 90
A questionnaire was administered to all patients to evaluate the acceptability of the Artificial Tears (referred to as AT). Percentage of patients responding either "Agree" or "Strongly Agree" at day 90 was tabulated. The potential response categories included "Strongly Agree", "Agree", "Neither Agree Nor Disagree", "Disagree" and "Strongly Disagree".
Time frame: Day 90
Patient Acceptability (Sensory) - Percentage of Patients Who Rated Artificial Tears (AT) as Acceptable at Day 90
A patient acceptability - sensory questionnaire was administered to all patients to evaluate the acceptability of the Artificial Tears (AT). Percentage of patients responding either "Agree" or "Strongly Agree" at day 90 was tabulated. The potential response categories included "Strongly Agree", "Agree", "Neither Agree Nor Disagree", "Disagree" and "Strongly Disagree".
Time frame: Day 90
Best Corrected Visual Acuity (BCVA) Status at Day 90
BCVA status at Day 90 reported as the number of patients whose scores were either "Better", "No Change", or "Worse" than their scores at baseline. The status was tabulated as number of lines read correctly at Day 90 minus the number of lines read correctly at baseline. "Better" equals increase of 2 lines or more; "No Change" equals change between -2 to +2 lines; "Worse" equals decrease of 2 lines or more. BCVA is measured using a special eye chart a nd is reported as the number of lines (5 letters per line) read correctly.
Time frame: Day 90
Change From Baseline of the Worse Eye in Corneal Topography as Measured by Pentacam at Day 90
Change from Baseline in corneal topography of the worse eye as measured using a Pentacam system which calculates a number. Corneal topography is a non-invasive medical imaging technique for mapping the surface of the eye. The Pentacam system measures the pupil and anterior segment (the front part of the eye) which provides a range from 10 (best) to 60 (worst). A negative number change from baseline indicates an improvement.
Time frame: Baseline, Day 90
Change From Baseline of the Worse Eye in Corneal Topography Measured by Humphrey Atlas at Day 90
Change from Baseline in corneal topography of the worse eye as measured by a Humphrey Atlas system which calculates a number. Corneal topography is anon-invasive medical imaging technique for mapping the surface curvature of the cornea (the outer structure of the eye). The higher the number the more irregular the cornea. A Humphrey Atlas system detects irregular conditions in the cornea with a range from 0 = best to 2.5 = worst. A negative number change from baseline indicates an improvement.
Time frame: Baseline, Day 90
Change From Baseline of Total Higher Order Aberration (HOA) of the Worse Eye at Day 90
Change from Baseline in total HOA of the worse eye. The total HOA number is measured using a machine that calculates and detects changes in the cornea which could occur post Lasik surgery. A negative number change from baseline indicates an improvement.
Time frame: Baseline, Day 90
Change From Baseline of the Worse Eye in Schirmer's Test at Day 90
Change from baseline in Schirmer's Test results at Day 90 in the worse eye. The Schirmer's Test measures the rate of the secretion of tears produced by the eye over 5 minutes. The results indicate the presence of dry eye (Normal = greater than or equal to 15 millimeters (mm) of tears, Dry Eye = less than 15 mm of tears). The smaller the number, the more severe the dry eye.
Time frame: Baseline, Day 90
Change From Baseline of the Worse Eye in Corneal Staining With Fluorescein at Day 90
Change from Baseline in corneal staining of the worse eye at Day 90. Sum of corneal staining over 5 zones; each zone was measured on a modified Oxford Scheme (0 = no staining and 5 = severe staining), for a minimum score of 0 and a maximum score of 25. The higher the grade score, the worse the dry eye condition. A negative change from baseline represents a decrease in corneal staining (improvement).
Time frame: Baseline, Day 90
Change From Baseline of the Worse Eye in Conjunctival Staining With Lissamine Green at Day 90
Change from Baseline in conjunctival staining of the worse eye using Lissamine Green staining procedure. Sum of conjunctival staining over 6 zones; each zone was measured on a modified Oxford Scheme (0 = no staining and 5 = severe staining), with a minimum score of 0 and a maximum score of 30. The higher the grade score, the worse dry eye condition. A negative number change from baseline represents a decrease in corneal staining (improvement).
Time frame: Baseline, Day 90
Change From Baseline of the Worse Eye in Tear Break-Up Time (TBUT) at Day 90
Change from Baseline in TBUT of the worse eye at Day 90. TBUT is the time required for dry spots to appear on the surface of the eye after blinking. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. A positive number change from baseline indicates an increase in TBUT (improvement).
Time frame: Baseline, Day 90
Change From Baseline in Study Product Usage at Day 90
Change from baseline in the study product usage (average number of uses per day) at Day 90. A negative number change from baseline indicates a reduction in eye drop usage (improvement).
Time frame: Baseline, Day 90
Number of Patients Prescribed to Each Dosing Regimen at Day 14 and Day 60
Number of patients prescribed to each dosing regimen at Day 14 and Day 60. At each visit from Day 14 (the first post-operative visit) to Day 60, patients were prescribed to 1 to 4 dosing regimens based on the investigator's clinical evaluation. Dosing schedule options were: At least every 2 hours while awake, 6 to 8 times per day, 3 to 5 times per day, at 1 to 2 times per day.
Time frame: Day 14, Day 60
| Milestone | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Started | 114 | 114 |
| Completed | 111 | 109 |
| Not completed | 3 | 5 |
Measured on 12 domains (categories); a 5-point scale for each domain (0 = best, no dry eye symptoms, 4 = worst, constant dry eye symptoms). Sum of the domain scores is normalized (standardized) to a severity scale of 0-100 (0 = no symptoms (best score), 100 = maximum severity (worst score)).
| Scores on a Scale | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Post LASIK Dry Eye Symptoms as Measured by Ocular Surface Disease Index (OSDI©) Score at Day 90 | 8.32 ± 11.125 | 6.43 ± 8.036 |
A questionnaire was administered to all patients to evaluate the acceptability of the Artificial Tears (referred to as AT). Percentage of patients responding either "Agree" or "Strongly Agree" at day 90 was tabulated. The potential response categories included "Strongly Agree", "Agree", "Neither Agree Nor Disagree", "Disagree" and "Strongly Disagree".
| Percentage of Patients | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Liked using these AT (112/110) | 88.4 | 93.6 |
| AT helped eyes feel comfortable (112/110) | 94.6 | 94.5 |
| AT were soothing to eyes (111/110) | 95.5 | 95.4 |
| AT protected eyes from dryness (112/109) | 88.4 | 89.9 |
| AT protected eyes from low humidity (112/110) | 78.6 | 82.7 |
| Vision was normal few min.after AT use(112/110) | 93.8 | 92.7 |
| Few min. after use, AT gave clear vision(111/110) | 94.6 | 94.5 |
| AT helped eyes heal from surgery (112/110) | 83.9 | 86.4 |
| AT helped eyes feel same as pre-LASIK (111/110) | 85.6 | 89.1 |
| It's good to use AT after surgery(111/109) | 97.3 | 96.3 |
A patient acceptability - sensory questionnaire was administered to all patients to evaluate the acceptability of the Artificial Tears (AT). Percentage of patients responding either "Agree" or "Strongly Agree" at day 90 was tabulated. The potential response categories included "Strongly Agree", "Agree", "Neither Agree Nor Disagree", "Disagree" and "Strongly Disagree".
| Percentage of Patients | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Thickness of AT is just right (112/109) | 79.5 | 87.2 |
| AT did not interfere with vision (112/108) | 64.3 | 82.4 |
| AT did not cause my eyes to get crusty (112/108) | 66.1 | 80.6 |
| AT were easy to use (112/109) | 99.1 | 99.1 |
| AT were convenient to use (112/109) | 96.4 | 91.7 |
| AT were important to a good outcome (111/109) | 82.0 | 80.7 |
| AT were helpful to achieve comfort (112/109) | 92.0 | 93.6 |
| AT were helpful to achieve good vision (112/109) | 71.4 | 76.1 |
| I no longer feel I need to use AT (111/108) | 43.2 | 38.0 |
BCVA status at Day 90 reported as the number of patients whose scores were either "Better", "No Change", or "Worse" than their scores at baseline. The status was tabulated as number of lines read correctly at Day 90 minus the number of lines read correctly at baseline. "Better" equals increase of 2 lines or more; "No Change" equals change between -2 to +2 lines; "Worse" equals decrease of 2 lines or more. BCVA is measured using a special eye chart a nd is reported as the number of lines (5 letters per line) read correctly.
| Number of Patients | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Better | 8 | 7 |
| No Change | 104 | 107 |
| Worse | 1 | 0 |
Change from Baseline in corneal topography of the worse eye as measured using a Pentacam system which calculates a number. Corneal topography is a non-invasive medical imaging technique for mapping the surface of the eye. The Pentacam system measures the pupil and anterior segment (the front part of the eye) which provides a range from 10 (best) to 60 (worst). A negative number change from baseline indicates an improvement.
| Units on a scale | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 31.95 ± 11.941 | 32.32 ± 15.347 |
| Change from Baseline at Day 90 | -2.12 ± 6.321 | -2.24 ± 6.267 |
Change from Baseline in corneal topography of the worse eye as measured by a Humphrey Atlas system which calculates a number. Corneal topography is anon-invasive medical imaging technique for mapping the surface curvature of the cornea (the outer structure of the eye). The higher the number the more irregular the cornea. A Humphrey Atlas system detects irregular conditions in the cornea with a range from 0 = best to 2.5 = worst. A negative number change from baseline indicates an improvement.
| Units on a scale | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 1.32 ± 0.855 | 1.25 ± 0.456 |
| Change from Baseline at Day 90 | -0.49 ± 0.899 | -0.26 ± 0.396 |
Change from Baseline in total HOA of the worse eye. The total HOA number is measured using a machine that calculates and detects changes in the cornea which could occur post Lasik surgery. A negative number change from baseline indicates an improvement.
| Microns | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 0.521 ± 0.1842 | 0.520 ± 0.1845 |
| Change from Baseline at Day 90 | -0.058 ± 0.1509 | -0.047 ± 0.1452 |
Change from baseline in Schirmer's Test results at Day 90 in the worse eye. The Schirmer's Test measures the rate of the secretion of tears produced by the eye over 5 minutes. The results indicate the presence of dry eye (Normal = greater than or equal to 15 millimeters (mm) of tears, Dry Eye = less than 15 mm of tears). The smaller the number, the more severe the dry eye.
| Millimeters of Tears | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 16.3 ± 8.40 | 13.5 ± 6.30 |
| Change from Baseline at Day 90 | -0.3 ± 8.75 | 1.7 ± 9.59 |
Change from Baseline in corneal staining of the worse eye at Day 90. Sum of corneal staining over 5 zones; each zone was measured on a modified Oxford Scheme (0 = no staining and 5 = severe staining), for a minimum score of 0 and a maximum score of 25. The higher the grade score, the worse the dry eye condition. A negative change from baseline represents a decrease in corneal staining (improvement).
| Scores on a Scale | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 0.5 ± 1.13 | 0.5 ± 1.12 |
| Change from Baseline at Day 90 | 0.0 ± 1.12 | 0.0 ± 1.47 |
Change from Baseline in conjunctival staining of the worse eye using Lissamine Green staining procedure. Sum of conjunctival staining over 6 zones; each zone was measured on a modified Oxford Scheme (0 = no staining and 5 = severe staining), with a minimum score of 0 and a maximum score of 30. The higher the grade score, the worse dry eye condition. A negative number change from baseline represents a decrease in corneal staining (improvement).
| Scores on a Scale | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 1.0 ± 1.98 | 0.8 ± 1.32 |
| Change from Baseline at Day 90 | 0.0 ± 1.65 | -0.3 ± 1.24 |
Change from Baseline in TBUT of the worse eye at Day 90. TBUT is the time required for dry spots to appear on the surface of the eye after blinking. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. A positive number change from baseline indicates an increase in TBUT (improvement).
| Number of seconds | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline | 13.66 ± 6.133 | 13.25 ± 5.250 |
| Change from Baseline at Day 90 | -0.92 ± 6.013 | -0.87 ± 12.924 |
Number of patients prescribed to each dosing regimen at Day 14 and Day 60. At each visit from Day 14 (the first post-operative visit) to Day 60, patients were prescribed to 1 to 4 dosing regimens based on the investigator's clinical evaluation. Dosing schedule options were: At least every 2 hours while awake, 6 to 8 times per day, 3 to 5 times per day, at 1 to 2 times per day.
| Number of patients | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Day 14: at least every 2 hrs (113/110) | 20 | 22 |
| Day 14: 6-8 times a day (113/110) | 30 | 30 |
| Day 14: 3-5 times a day (113/110) | 58 | 54 |
| Day 14: 1-2 times a day (113/110) | 5 | 4 |
| Day 60: at least every 2 hrs (109/107) | 4 | 3 |
| Day 60: 6-8 times a day (109/107) | 12 | 14 |
| Day 60: 3-5 times a day (109/107) | 62 | 60 |
| Day 60: 1-2 times a day (109/107) | 31 | 30 |
Change from baseline in the study product usage (average number of uses per day) at Day 90. A negative number change from baseline indicates a reduction in eye drop usage (improvement).
| Number of study product uses per day | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Baseline (108/108) | 7.9 ± 3.16 | 7.9 ± 4.89 |
| Change from Baseline at Day 90 (108/105) | -4.9 ± 3.38 | -4.5 ± 5.97 |
Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Carboxymethylcellulose and Glycerin Based Artificial Tear | — | 0/114 (0%) | 88/114 (77.2%) |
| Carboxymethylcellulose Based Artificial Tear | — | 0/114 (0%) | 82/114 (71.9%) |
| Event | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear |
|---|---|---|
| Punctate KeratitisEye disorders | 21/114 | 22/114 |
| Halo VisionEye disorders | 10/114 | 9/114 |
| Dry EyeEye disorders | 10/114 | 8/114 |
| GlareEye disorders | 8/114 | 7/114 |
| Conjucntival HaemorrhageEye disorders | 8/114 | 6/114 |
| NasopharyngitisInfections and infestations | 8/114 | 6/114 |
| Eye Operation ComplicationsInjury, poisoning and procedural complications | 7/114 | 5/114 |
| PhotophobiaEye disorders | 5/114 | 7/114 |
| Foreign Body Sensation in EyesEye disorders | 6/114 | 6/114 |
| Ocular discomfortEye disorders | 5/114 | 6/114 |
| Age, Customized(participants) | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear | Total |
|---|---|---|---|
| <40 Years | 88 | 92 | 180 |
| >= 40 Years | 26 | 22 | 48 |
| Sex: Female, Male(Participants) | Carboxymethylcellulose and Glycerin Based Artificial Tear | Carboxymethylcellulose Based Artificial Tear | Total |
|---|---|---|---|
| Female | 62 | 51 | 113 |
| Male | 52 | 63 | 115 |
The record gives a start of Sep 2007, a primary completion of Jun 2008 and a completion of Jun 2008. It does not say whether these dates are actual or estimated.
Results were first posted in Dec 2011, 3 years 6 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.